PeerVoice Immunology & Infectious Disease Video

PeerVoice
  • 0.0 (0)
  • SCIENCE
PeerVoice Immunology & Infectious Disease Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 11 OCT

    Janet Pope, MD, MPH, FRCPC - Understanding the Relevance of Rheumatoid Factor Titers in Rheumatoid Arthritis: From Prognosis to Treatment

    Visit https://www.peervoice.com/VWE860 to view the entire programme with slides. After completing “Janet Pope, MD, MPH, FRCPC - Understanding the Relevance of Rheumatoid Factor Titers in Rheumatoid Arthritis: From Prognosis to Treatment”, participants will be able to: Recognize rheumatoid factor (RF) as a poor prognostic marker in rheumatoid arthritis (RA); Explain how RF may impact serum drug levels and response to biologic therapy; and Evaluate the latest data with biologic therapies showcasing clinical outcomes according to RF titers.

    11 min

  2. 30 SEPT

    Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey

    Visit https://www.peervoice.com/NXY860 to view the entire programme with slides. After completing “Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey”, participants will be able to: Differentiate the symptoms, causes and outcomes associated with childhood-onset and adult-onset presentations of mastocytosis; Utilise recommended clinical tools for the evaluation of symptoms and quality of life (QoL) in patients with indolent systemic mastocytosis (ISM); and Implement evidence-based best practices in the diagnosis, monitoring and management of ISM.

    29 min

  3. 27 AUG

    Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?

    Visit https://www.peervoice.com/VZX860 to view the entire programme with slides. After completing “Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?”, participants will be able to: Explain the rationale for switching antiretroviral therapy (ART) regimens in people with virologically suppressed HIV; Assess the clinical and patient-reported outcomes (PRO) data for HIV switch regimens for people with virologically suppressed HIV; and Based on clinical trial populations, evaluate eligibility criteria of people with virologically suppressed HIV for an ART switch.

    19 min

  4. 23 AUG

    Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?

    Visit https://www.peervoice.com/FDX860 to view the entire programme with slides. After completing “Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?”, participants will be able to: Summarise the rationale for integrating patient-reported outcomes (PRO) instruments into routine clinical practice when caring for people living with HIV; Explain how PRO measures (PROM) can be effectively integrated into routine clinical practice; Identify how PRO can inform HIV treatment plans that optimise outcomes; and Propose practical approaches to overcoming communication challenges when exploring quality of life (QoL) alongside clinical outcomes with people living with HIV.

    46 min

  5. 12 AUG

    Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA

    Visit https://www.peervoice.com/YBG860 to view the entire programme with slides. After completing “Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA”, participants will be able to: Discuss unmet needs in the management of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA); Evaluate the evidence with new targeted therapies for PsA and axSpA; and Outline the clinical implications with new therapies for the management of patients with PsA and axSpA.

    16 min

  6. 10 JUL

    Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA

    Visit https://www.peervoice.com/AFQ860 to view the entire programme with slides. After completing “Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA”, participants will be able to: Describe the rationale, design, and key areas of focus of the Rheumacensus programmes in psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA); Identify the overarching calls to action needed to implement a paradigm shift designed to elevate health outcomes in patients with PsA and axSpA, as defined by the Rheumacensus Consensus Council; and Propose practical steps to elevate the standard of care for patients with PsA and axSpA based upon results of the Rheumacensus Initiatives.

    15 min

  7. 25 JUN

    Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making

    Visit https://www.peervoice.com/HUM860 to view the entire programme with slides. After completing “Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making”, participants will be able to: Describe key information regarding the disease process and course following the diagnosis of generalized pustular psoriasis (GPP); Address common concerns raised by patients with GPP; and Develop appropriate treatment plans with patients for the management of GPP.

    34 min

  8. 30 MAY

    Mohamed El-Hussein, RN, PhD, NP / Caitlin Carreau, MN, RN(EC) - At the Forefront of Cancer Prevention: Nursing Strategies to Optimize HPV Immunization

    Visit https://www.peervoice.com/QQB860 to view the entire programme with slides. After completing “Mohamed El-Hussein, RN, PhD, NP / Caitlin Carreau, MN, RN(EC) - At the Forefront of Cancer Prevention: Nursing Strategies to Optimize HPV Immunization”, participants will be able to: Describe the various cancer risks in adults that have been linked to human papillomavirus (HPV) infection; Discuss the latest clinical evidence with HPV vaccines; Discuss HPV prevention measures and how nurses can integrate HPV prevention in their clinical practice; and Outline nursing strategies to improve HPV vaccination rates in adults through multidisciplinary collaboration.

    21 min
See All (60)

About

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Information

More From PeerVoice

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada